Bibliography
- In: British National Formulary. Number 48, Pharmaceutical Press and British Medical Association, London (2004).
- Ogra PL, et al. (Eds.), 2nd edition, Academic Press, San Diego (1999):1047–1053.
- Ogra PL, et al. (Eds.), 2nd edition, Academic Press, San Diego (1999):1055–1080.
- O'Morain CA (Ed.), CRC Press, Boca Raton (1991):139–151.
- LOFTUS EV: Clinical epidemiology of inflammatory bowel disease: incidence, prevalence and environmental influences. Gastroenterology (2004) 126:1504–1517.
- Sweetman SC (Ed.), 33rd edition, Pharmaceutical Press, London (2002):1205–1206.
- NAYAR M, RHODES JM: Management of inflammatory bowel disease. Postgrad. Med. J. (2004) 80:206–213.
- WATTS PJ, ILLUM L: Colonic drug delivery. Drug Dev. Ind. Pharm. (1997) 23:893–913.
- ••General review of the field of colonic drugdelivery.
- CHOURASIA MK, JAIN SK: Pharmaceutical approaches to colon targeted drug delivery systems. J. Pharm. Pharmaceut. Sci. (2003) 6:33–66.
- ••General review of the field of colonic drugdelivery
- YANG L, CHU JS, FIX JA: Colon-specific drug delivery: new approaches and in vitro! in vivo evaluation. Int. j Pharm. (2002) 235:1–15.
- ••General review of the field of colonic drugdelivery
- Moded Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):217–222.
- Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):223–232.
- Moded Release Drug Delivery Technology. Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):233–242.
- Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):243–248.
- DAVIS SS, HARDY JG, FARA JW: Transit of pharmaceutical dosage forms through the small intestine. Gut (1986) 27:886–892.
- MILOJEVIC S, NEWTON JM, CUMMINGS JH et al.: Amylose as a coating for drug delivery to the colon: Preparation and in vitro evaluation using glucose pellets. J. Control. Rel. (1996) 38:85–94.
- KATSUMA M, WATANABE S, TAKEMURA S et al.: Scintigraphic evaluation of a novel colon-targeted delivery system (CODESTm) in healthy volunteers. Pharm. Sci. (2004) 93:1287–1299.
- Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York, (2003):257–262.
- POZZI F, FURLANI P, GAZZANIGA A, DAVIS SS, WILDING IR: The TIME CLOCK system: a new oral dosage form for fast and complete release of drug after a predetermined lag time. J. Control. Rel. (1994) 31:99–108.
- GOLDBERG M, GOMEZ-ORELLANA I: Challenges for the oral delivery of macromolecules. Nat. Rev. Drug Discov. (2003) 2:289–295.
- •Overview of strategies for oral peptide and protein delivery
- SCHROEDER KW, TREMAINE WJ, ILSTRUP DL: Coated 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. N Engl J. Med. (1987) 317:1625–1629.
- VILIVALAM VD, ILLUM L, IQBAL K: Starch capsules: an alternative system for oral drug delivery. Pharm. Sci. TechnoL Today (2000) 3:64–69.
- ••Reviews production, properties and uses ofstarch capsules, which are a key component of TARGITTm technology.
- Banker GS, Rhodes CT (Eds.), 3rd edition, Marcel Dekker, New York (1990:395–440.
- HOWE D, GARRELL R, D'ANDREA L, IQBAL K: Development and evaluation of a hot melt formulation in enteric coated starch capsules. AAPS Pharm. (2001) 3(3).
- Rowe RC, Shesky PJ, Weller PJ (Eds.): Handbook of Pharmaceutical Excipients. 4th Edition, Pharmaceutical Press, London (2003).
- WILDING IR, COUPE AJ, DAVIS SS: The role of gamma-scintigraphy in oral drug delivery. Adv. Drug Deli v. Rev. (2001) 46:103–124.
- SKALSKY B, RUDOLPH M, RENNER G: In-vivo evaluation of EUDRACOLTm: a novel pH- and time-controlled multiple unit colonic drug delivery system. Transactions of Controlled Release Society 31st Annual Meeting (2004): Abstract 051.
- Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):101–114.
- Rathbone MJ, Hadgraft J, Roberts MS (Eds.), Marcel Dekker, New York (2003):273–288.
Websites
- http://www.alizyme.com